Strange #265

Jan 1992 · Semic S.A. · 18,00 FRF

🌐 French edition · synopsis shown in English

☆ Be the first to review + Add to your collection — Join free

“Grands maux, grands remèdes...”

In "Grands maux, grands remèdes...", Spider-Man races against time to secure a rare element from Doctor Octopus to combat a spreading atmospheric poison. Meanwhile, Jonathon Caesar makes one final move for Mary Jane, only to meet an unexpected end at the hands of a police-affiliated fan. Written by David Michelinie and drawn by Erik Larsen, with inks by Randy Emberlin, Mike Machlan, Keith Williams, and John Romita, and vibrant colors by Bob Sharen, Gregory Wright, and Mike Rockwitz, this 1992 issue delivers high-stakes tension and emotional weight. The cover by Paul Ryan and Tom Palmer captures the urgency of the moment.

Was this helpful and accurate?

writer David Michelinie · artist Erik Larsen · inker Randy Emberlin · inker Mike Machlan · inker Keith Williams · inker John Romita · colorist Bob Sharen · colorist Gregory Wright · colorist Mike Rockwitz · cover Paul Ryan, Tom Palmer

Find on ebay

Search eBay for Strange #265 ▸

No confirmed live listings for this exact issue right now — this opens an eBay search.

Sell my copy

Have this issue — or a whole collection? Get a fair offer from us, skip the marketplace fees and the hassle.

We Buy Collections ▸

Fast, fair offers · we handle grading & shipping

Full credits

writer David Michelinie

artist Erik Larsen

inker Randy Emberlin

inker Mike Machlan

inker Keith Williams

inker John Romita

colorist Bob Sharen

colorist Gregory Wright

colorist Mike Rockwitz

cover pencils Paul Ryan

cover inks Tom Palmer

Full plot ⚠ may contain spoilers

▸ Reveal full plot — may contain spoilers

Spidey rushes to obtain a rare element from Doc Ock to counteract the poison in the atmosphere. Jonathon Caesar makes another play for MJ and is killed by one of her fans who works for the police.

Plot details indexed by the Grand Comics Database (CC BY-SA).

Reviews

Reader reviews

No reader reviews yet.